Free Trial

Cardio Diagnostics (CDIO) Competitors

Cardio Diagnostics logo
$4.28 -0.05 (-1.15%)
Closing price 03:59 PM Eastern
Extended Trading
$4.43 +0.15 (+3.60%)
As of 07:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CDIO vs. DARE, ENLV, CVKD, PASG, LPTX, PMN, LNAI, CASI, MIRA, and TAOX

Should you be buying Cardio Diagnostics stock or one of its competitors? The main competitors of Cardio Diagnostics include Dare Bioscience (DARE), Enlivex Therapeutics (ENLV), Cadrenal Therapeutics (CVKD), Passage Bio (PASG), Leap Therapeutics (LPTX), Promis Neurosciences (PMN), Lunai Bioworks (LNAI), CASI Pharmaceuticals (CASI), MIRA Pharmaceuticals (MIRA), and Synaptogenix (TAOX). These companies are all part of the "pharmaceutical products" industry.

Cardio Diagnostics vs. Its Competitors

Dare Bioscience (NASDAQ:DARE) and Cardio Diagnostics (NASDAQ:CDIO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, media sentiment, institutional ownership, earnings and profitability.

6.7% of Dare Bioscience shares are held by institutional investors. Comparatively, 8.1% of Cardio Diagnostics shares are held by institutional investors. 4.8% of Dare Bioscience shares are held by insiders. Comparatively, 13.3% of Cardio Diagnostics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Dare Bioscience has higher earnings, but lower revenue than Cardio Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dare Bioscience$10K2,736.44-$4.05M-$2.14-0.95
Cardio Diagnostics$40K188.32-$8.38MN/AN/A

In the previous week, Dare Bioscience and Dare Bioscience both had 1 articles in the media. Dare Bioscience's average media sentiment score of 1.82 beat Cardio Diagnostics' score of 1.45 indicating that Dare Bioscience is being referred to more favorably in the media.

Company Overall Sentiment
Dare Bioscience Very Positive
Cardio Diagnostics Positive

Dare Bioscience has a beta of 1.14, indicating that its stock price is 14% more volatile than the S&P 500. Comparatively, Cardio Diagnostics has a beta of 2.91, indicating that its stock price is 191% more volatile than the S&P 500.

Dare Bioscience has a net margin of 0.00% compared to Cardio Diagnostics' net margin of -30,465.10%. Dare Bioscience's return on equity of 0.00% beat Cardio Diagnostics' return on equity.

Company Net Margins Return on Equity Return on Assets
Dare BioscienceN/A N/A -103.70%
Cardio Diagnostics -30,465.10%-72.78%-66.17%

Dare Bioscience currently has a consensus target price of $10.00, suggesting a potential upside of 392.61%. Given Dare Bioscience's stronger consensus rating and higher possible upside, equities analysts plainly believe Dare Bioscience is more favorable than Cardio Diagnostics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Dare Bioscience
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Cardio Diagnostics
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Dare Bioscience beats Cardio Diagnostics on 8 of the 13 factors compared between the two stocks.

Get Cardio Diagnostics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDIO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CDIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CDIO vs. The Competition

MetricCardio DiagnosticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$7.53M$3.41B$6.08B$10.54B
Dividend YieldN/A2.29%5.73%4.78%
P/E RatioN/A22.5884.6327.10
Price / Sales188.32484.96606.15130.49
Price / CashN/A46.9737.8662.13
Price / Book0.6010.4112.246.58
Net Income-$8.38M-$52.47M$3.32B$276.75M
7 Day Performance3.13%2.30%0.76%0.92%
1 Month Performance10.88%14.45%8.03%4.20%
1 Year Performance-32.48%12.90%71.13%37.86%

Cardio Diagnostics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CDIO
Cardio Diagnostics
1.5187 of 5 stars
$4.28
-1.2%
N/A-36.3%$7.53M$40K0.001Short Interest ↓
DARE
Dare Bioscience
2.5133 of 5 stars
$2.12
flat
$10.00
+371.7%
-40.8%$28.58M$10K-0.9930Positive News
ENLV
Enlivex Therapeutics
3.3282 of 5 stars
$1.10
-4.3%
$10.00
+809.1%
-35.2%$27.94MN/A-1.9070
CVKD
Cadrenal Therapeutics
2.9427 of 5 stars
$13.99
+2.7%
$32.00
+128.7%
-10.0%$27.88MN/A-1.584
PASG
Passage Bio
3.5003 of 5 stars
$8.69
+2.6%
$75.67
+770.7%
-32.1%$26.93MN/A-0.48130Gap Up
LPTX
Leap Therapeutics
2.6707 of 5 stars
$0.60
-5.5%
$3.38
+459.6%
-76.1%$26.46MN/A-0.3840Short Interest ↓
Gap Up
PMN
Promis Neurosciences
3.8255 of 5 stars
$0.48
-2.0%
$4.33
+802.8%
-55.1%$26.37MN/A-2.295Short Interest ↓
Gap Down
LNAI
Lunai Bioworks
N/A$1.16
+2.7%
N/AN/A$26.19MN/A-0.1520News Coverage
CASI
CASI Pharmaceuticals
4.011 of 5 stars
$1.89
-4.5%
$4.00
+111.6%
-68.5%$24.35M$28.54M-0.65180Analyst Forecast
MIRA
MIRA Pharmaceuticals
0.4475 of 5 stars
$1.29
+2.0%
N/A+63.6%$24.03MN/A-2.622News Coverage
Gap Down
TAOX
Synaptogenix
0.0562 of 5 stars
$9.54
+38.5%
N/AN/A$24.03MN/A-0.474Gap Up
High Trading Volume

Related Companies and Tools


This page (NASDAQ:CDIO) was last updated on 10/17/2025 by MarketBeat.com Staff
From Our Partners